0001209191-18-025306.txt : 20180418
0001209191-18-025306.hdr.sgml : 20180418
20180418130019
ACCESSION NUMBER: 0001209191-18-025306
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180417
FILED AS OF DATE: 20180418
DATE AS OF CHANGE: 20180418
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Boyce Sarah
CENTRAL INDEX KEY: 0001629383
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38137
FILM NUMBER: 18760746
MAIL ADDRESS:
STREET 1: C/O IONIS PHARMACEUTICALS, INC.
STREET 2: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001662524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472608175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 55 CAMBRIDGE PARKWAY
STREET 2: SUITE 100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 760-603-2732
MAIL ADDRESS:
STREET 1: 2855 GAZELLE CT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-04-17
0
0001662524
AKCEA THERAPEUTICS, INC.
AKCA
0001629383
Boyce Sarah
C/O AKCEA THERAPEUTICS, INC.
55 CAMBRIDGE PARKWAY, STE. 100
CAMBRIDGE
MA
02142
1
1
0
0
President
Common Stock
2018-04-17
4
A
0
20894
0.00
A
20894
D
Stock Option (right to buy)
23.93
2018-04-17
4
A
0
1000000
0.00
A
2028-04-16
Common Stock
1000000
1000000
D
The shares vest as follows: 1/4th of the shares vest one year after April 17, 2018;1/48th of the shares vest monthly thereafter over the next three years.
/s/ Sarah Boyce
2018-04-18